CSTF3 Contributes to Platinum Resistance in Ovarian Cancer Through Alternative Polyadenylation of LncRNA NEAT1 and Generating the Short Isoform NEAT1_1

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2024 Jun 19

PMID 38898019

Authors

Xin Luo

Qinglv Wei

Xiaoyan Jiang

Ningxuan Chen

Xinzhao Zuo

Hongyan Zhao

Yujiao Liu

Xiaoyi Liu

Lingcui Xie

Yu Yang

Tao Liu

Ping Yi

Jing Xu

Affiliations

Soon will be listed here.

Abstract

Platinum-based chemotherapy is the standard postoperative adjuvant treatment for ovarian cancer (OC). Despite the initial response to chemotherapy, 85% of advanced OC patients will have recurrent disease. Relapsed disease and platinum resistance are the major causes of death in OC patients. In this study, we compared the global regulation of alternative polyadenylation (APA) in platinum-resistant and platinum-sensitive tissues of OC patients by analyzing a set of single-cell RNA sequencing (scRNA-seq) data from public databases and found that platinum-resistant patients exhibited global 3' untranslated region (UTR) shortening due to the different usage of polyadenylation sites (PASs). The APA regulator CSTF3 was the most significantly upregulated gene in epithelial cells of platinum-resistant OC. CSTF3 knockdown increased the sensitivity of OC cells to platinum. The lncRNA NEAT1 has two isoforms, short (NEAT1_1) and long (NEAT1_2) transcript, because of the APA processing in 3'UTR. We found that CSTF3 knockdown reduced the usage of NEAT1 proximal PAS to lengthen the transcript and facilitate the expression of NEAT1_2. Downregulation of the expression of NEAT1 (NEAT1_1/_2), but not only NEAT1_2, also increased the sensitivity of OC cells to platinum. Overexpressed NEAT1_1 reversed the platinum resistance of OC cells after knocking down CSTF3 expression. Furthermore, downregulated expression of CSTF3 and NEAT1_1, rather than NEAT1_2, was positively correlated with inactivation of the PI3K/AKT/mTOR pathway in OC cells. Together, our findings revealed a novel mechanism of APA regulation in platinum-resistant OC. CSTF3 directly bound downstream of the NEAT1 proximal PAS to generate the short isoform NEAT1_1 and was conducive to platinum resistance, which provides a potential biomarker and therapeutic strategy for platinum-resistant OC patients.

Citing Articles

Identifying the ceRNA Regulatory Network in Early-Stage Acute Pancreatitis and Investigating the Therapeutic Potential of NEAT1 in Mouse Models.

Lin B, Huang C J Inflamm Res. 2024; 17:8099-8115.

PMID: 39507263 PMC: 11539775. DOI: 10.2147/JIR.S490315.

References

Gruber A, Zavolan M . Alternative cleavage and polyadenylation in health and disease. Nat Rev Genet. 2019; 20(10):599-614. DOI: 10.1038/s41576-019-0145-z. View

Del Campo J, Matulonis U, Malander S, Provencher D, Mahner S, Follana P . Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial. J Clin Oncol. 2019; 37(32):2968-2973. PMC: 6839909. DOI: 10.1200/JCO.18.02238. View

Odunsi K . Immunotherapy in ovarian cancer. Ann Oncol. 2017; 28(suppl_8):viii1-viii7. PMC: 5834124. DOI: 10.1093/annonc/mdx444. View

Pisani G, Baron B . NEAT1 and Paraspeckles in Cancer Development and Chemoresistance. Noncoding RNA. 2020; 6(4). PMC: 7712271. DOI: 10.3390/ncrna6040043. View

Moreno-Morcillo M, Minvielle-Sebastia L, Mackereth C, Fribourg S . Hexameric architecture of CstF supported by CstF-50 homodimerization domain structure. RNA. 2011; 17(3):412-8. PMC: 3039141. DOI: 10.1261/rna.2481011. View

Yan H, Wang Z, Sun Y, Hu L, Bu P . Cytoplasmic NEAT1 Suppresses AML Stem Cell Self-Renewal and Leukemogenesis through Inactivation of Wnt Signaling. Adv Sci (Weinh). 2021; 8(22):e2100914. PMC: 8596104. DOI: 10.1002/advs.202100914. View

Song M, Cui M, Liu K . Therapeutic strategies to overcome cisplatin resistance in ovarian cancer. Eur J Med Chem. 2022; 232:114205. DOI: 10.1016/j.ejmech.2022.114205. View

Li O, Jiang B, Yi W, Zhang Y, Yang P, Guo C . LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma. Kaohsiung J Med Sci. 2021; 37(5):379-391. DOI: 10.1002/kjm2.12354. View

Grozdanov P, Masoumzadeh E, Latham M, MacDonald C . The structural basis of CstF-77 modulation of cleavage and polyadenylation through stimulation of CstF-64 activity. Nucleic Acids Res. 2018; 46(22):12022-12039. PMC: 6294498. DOI: 10.1093/nar/gky862. View

10.

Barra J, Gaidosh G, Blumenthal E, Beckedorff F, Tayari M, Kirstein N . Integrator restrains paraspeckles assembly by promoting isoform switching of the lncRNA . Sci Adv. 2020; 6(27):eaaz9072. PMC: 7455494. DOI: 10.1126/sciadv.aaz9072. View

11.

Fontana G, Rigamonti A, Lenzken S, Filosa G, Alvarez R, Calogero R . Oxidative stress controls the choice of alternative last exons via a Brahma-BRCA1-CstF pathway. Nucleic Acids Res. 2016; 45(2):902-914. PMC: 5314785. DOI: 10.1093/nar/gkw780. View

12.

Wu D, Li H, Wang J, Li H, Xiao Q, Zhao X . LncRNA NEAT1 promotes gastric cancer progression via miR-1294/AKT1 axis. Open Med (Wars). 2020; 15(1):1028-1038. PMC: 7718639. DOI: 10.1515/med-2020-0218. View

13.

An J, Lv W, Zhang Y . LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194. Onco Targets Ther. 2017; 10:5377-5390. PMC: 5691924. DOI: 10.2147/OTT.S147586. View

14.

Ren F, Zhang N, Zhang L, Miller E, Pu J . Alternative Polyadenylation: a new frontier in post transcriptional regulation. Biomark Res. 2020; 8(1):67. PMC: 7690165. DOI: 10.1186/s40364-020-00249-6. View

15.

Naganuma T, Nakagawa S, Tanigawa A, Sasaki Y, Goshima N, Hirose T . Alternative 3'-end processing of long noncoding RNA initiates construction of nuclear paraspeckles. EMBO J. 2012; 31(20):4020-34. PMC: 3474925. DOI: 10.1038/emboj.2012.251. View

16.

Begik O, Oyken M, Cinkilli Alican T, Can T, Erson-Bensan A . Alternative Polyadenylation Patterns for Novel Gene Discovery and Classification in Cancer. Neoplasia. 2017; 19(7):574-582. PMC: 5476451. DOI: 10.1016/j.neo.2017.04.008. View

17.

Yalamanchili H, Alcott C, Ji P, Wagner E, Zoghbi H, Liu Z . PolyA-miner: accurate assessment of differential alternative poly-adenylation from 3'Seq data using vector projections and non-negative matrix factorization. Nucleic Acids Res. 2020; 48(12):e69. PMC: 7337927. DOI: 10.1093/nar/gkaa398. View

18.

Shulman E, Elkon R . Cell-type-specific analysis of alternative polyadenylation using single-cell transcriptomics data. Nucleic Acids Res. 2019; 47(19):10027-10039. PMC: 6821429. DOI: 10.1093/nar/gkz781. View

19.

Van Nostrand E, Pratt G, Shishkin A, Gelboin-Burkhart C, Fang M, Sundararaman B . Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nat Methods. 2016; 13(6):508-14. PMC: 4887338. DOI: 10.1038/nmeth.3810. View

20.

Geistlinger L, Oh S, Ramos M, Schiffer L, LaRue R, Henzler C . Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma. Cancer Res. 2020; 80(20):4335-4345. PMC: 7572645. DOI: 10.1158/0008-5472.CAN-20-0521. View